These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31199832)

  • 1. Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015.
    Sagiyev Z; Berdibekov A; Bolger T; Merekenova A; Ashirova S; Nurgozhin Z; Dalibayev Z
    PLoS One; 2019; 14(6):e0218366. PubMed ID: 31199832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a recombinant F1-V fusion protein vaccine intended to protect Canada lynx (Lynx canadensis) from plague.
    Wolfe LL; Shenk TM; Powell B; Rocke TE
    J Wildl Dis; 2011 Oct; 47(4):888-92. PubMed ID: 22102659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).
    Frey SE; Lottenbach K; Graham I; Anderson E; Bajwa K; May RC; Mizel SB; Graff A; Belshe RB
    Vaccine; 2017 Dec; 35(48 Pt B):6759-6765. PubMed ID: 29037578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis.
    Rocke TE; Smith S; Marinari P; Kreeger J; Enama JT; Powell BS
    J Wildl Dis; 2008 Jan; 44(1):1-7. PubMed ID: 18263816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.
    Feodorova VA; Lyapina AM; Khizhnyakova MA; Zaitsev SS; Sayapina LV; Arseneva TE; Trukhachev AL; Lebedeva SA; Telepnev MV; Ulianova OV; Lyapina EP; Ulyanov SS; Motin VL
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006511. PubMed ID: 29889829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Live Plague Vaccine Candidates.
    Feodorova VA; Sayapina LV; Motin VL
    Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history and incidence of Yersinia pestis and prospects for vaccination.
    Williamson ED; Oyston PCF
    J Med Microbiol; 2012 Jul; 61(Pt 7):911-918. PubMed ID: 22442294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries.
    Cui Y; Yang X; Xiao X; Anisimov AP; Li D; Yan Y; Zhou D; Rajerison M; Carniel E; Achtman M; Yang R; Song Y
    Infect Genet Evol; 2014 Aug; 26():172-9. PubMed ID: 24905600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of memory B cell and plasma cell responses in the mice immunized with plague vaccines.
    Zhang X; Wang Q; Bi Y; Kou Z; Zhou J; Cui Y; Yan Y; Zhou L; Tan Y; Yang H; Du Z; Han Y; Song Y; Zhang P; Zhou D; Yang R; Wang X
    Scand J Immunol; 2014 Mar; 79(3):157-62. PubMed ID: 24383627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
    Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
    Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.